Andreas Henke

3.1k total citations
73 papers, 2.5k citations indexed

About

Andreas Henke is a scholar working on Cardiology and Cardiovascular Medicine, Immunology and Molecular Biology. According to data from OpenAlex, Andreas Henke has authored 73 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Cardiology and Cardiovascular Medicine, 28 papers in Immunology and 27 papers in Molecular Biology. Recurrent topics in Andreas Henke's work include Viral Infections and Immunology Research (43 papers), interferon and immune responses (16 papers) and Viral gastroenteritis research and epidemiology (12 papers). Andreas Henke is often cited by papers focused on Viral Infections and Immunology Research (43 papers), interferon and immune responses (16 papers) and Viral gastroenteritis research and epidemiology (12 papers). Andreas Henke collaborates with scholars based in Germany, United States and United Kingdom. Andreas Henke's co-authors include A. Stelzner, Roland Zell, J. Lindsay Whitton, Sally A. Huber, Edgar Wagner, Marcelo Desimone, Thomas Münder, P Wutzler, Andi Krumbholz and Ulrike Martin and has published in prestigious journals such as Circulation, The Journal of Immunology and PLANT PHYSIOLOGY.

In The Last Decade

Andreas Henke

73 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andreas Henke Germany 28 1.3k 843 712 526 469 73 2.5k
Asim Dasgupta United States 28 789 0.6× 1.2k 1.4× 537 0.8× 263 0.5× 339 0.7× 50 2.3k
Decheng Yang Canada 32 1.7k 1.3× 1.7k 2.0× 528 0.7× 741 1.4× 619 1.3× 83 3.3k
A. Stelzner Germany 25 1.2k 0.9× 517 0.6× 528 0.7× 406 0.8× 425 0.9× 104 1.9k
Steven Tracy United States 30 1.4k 1.1× 637 0.8× 705 1.0× 351 0.7× 482 1.0× 74 2.4k
Hendrik Jan Thibaut Belgium 22 1.0k 0.8× 821 1.0× 845 1.2× 287 0.5× 467 1.0× 58 2.0k
Andrea Cuconati United States 31 414 0.3× 1.2k 1.4× 873 1.2× 542 1.0× 1.8k 3.8× 52 3.5k
Guangxiang Luo United States 39 313 0.2× 1.3k 1.6× 594 0.8× 433 0.8× 2.3k 4.9× 75 4.3k
Xiaoning Si Canada 22 500 0.4× 950 1.1× 183 0.3× 504 1.0× 451 1.0× 30 1.7k
A. John United States 17 431 0.3× 1.1k 1.4× 385 0.5× 112 0.2× 188 0.4× 25 2.0k
Yi Lasanajak United States 28 293 0.2× 1.6k 1.9× 225 0.3× 474 0.9× 449 1.0× 66 2.6k

Countries citing papers authored by Andreas Henke

Since Specialization
Citations

This map shows the geographic impact of Andreas Henke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Henke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Henke more than expected).

Fields of papers citing papers by Andreas Henke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Henke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Henke. The network helps show where Andreas Henke may publish in the future.

Co-authorship network of co-authors of Andreas Henke

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas Henke. A scholar is included among the top collaborators of Andreas Henke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas Henke. Andreas Henke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Egerer, Renate, Birgit Edel, Bettina Löffler, Andreas Henke, & Jürgen Rödel. (2021). Performance of the RT-LAMP-based eazyplex® SARS-CoV-2 as a novel rapid diagnostic test. Journal of Clinical Virology. 138. 104817–104817. 4 indexed citations
2.
Deinhardt‐Emmer, Stefanie, Daniel Wittschieber, C. M. Haring, et al.. (2021). Early postmortem mapping of SARS-CoV-2 RNA in patients with COVID-19 and the correlation with tissue damage. eLife. 10. 63 indexed citations
4.
Karrasch, Matthias, Elisabeth Fischer, Andreas Sauerbrei, et al.. (2016). A severe pediatric infection with a novel enterovirus A71 strain, Thuringia, Germany. Journal of Clinical Virology. 84. 90–95. 30 indexed citations
5.
Spengler, Katrin, et al.. (2014). Characterization of coxsackievirus B3 replication in human umbilical vein endothelial cells. Medical Microbiology and Immunology. 203(4). 217–229. 5 indexed citations
6.
Sauerbrei, Andreas, K. Bohn, Andreas Henke, et al.. (2012). Significance of amino acid substitutions in the thymidine kinase gene of herpes simplex virus type 1 for resistance. Antiviral Research. 96(2). 105–107. 17 indexed citations
7.
Bier, Carolin, Shirley K. Knauer, Kalsoom Sughra, et al.. (2012). Histone deacetylase inhibitors block IFNγ-induced STAT1 phosphorylation. Cellular Signalling. 24(7). 1453–1460. 39 indexed citations
8.
Schütze, Tatjana, et al.. (2011). Analysis of Different DNA Vaccines for Protection of Experimental Influenza A Virus Infection. Viral Immunology. 24(4). 321–330. 7 indexed citations
9.
Schmidtke, Michaela, et al.. (2010). Antibody-Dependent Enhancement of Coxsackievirus B3 Infection of Primary CD19 + B Lymphocytes. Viral Immunology. 23(4). 369–376. 14 indexed citations
10.
Henke, Andreas, et al.. (2008). Characterization of the Protective Capability of a Recombinant Coxsackievirus B3 Variant Expressing Interferon-γ. Viral Immunology. 21(1). 38–48. 13 indexed citations
11.
Saluz, H. P., et al.. (2008). Proapoptotic protein Siva binds to the muscle protein telethonin in cardiomyocytes during coxsackieviral infection. Cardiovascular Research. 81(1). 108–115. 7 indexed citations
12.
Krebs, Philippe, Michael Kurrer, Marcel Kremer, et al.. (2007). Molecular mapping of autoimmune B cell responses in experimental myocarditis. Journal of Autoimmunity. 28(4). 224–233. 20 indexed citations
13.
Martin, Ulrike, et al.. (2007). Influence of pan-caspase inhibitors on coxsackievirus B3-infected CD19+ B lymphocytes. APOPTOSIS. 12(9). 1633–1643. 19 indexed citations
14.
Henke, Andreas, et al.. (2007). Recombinant coxsackievirus vectors for prevention and therapy of virus-induced heart disease. International Journal of Medical Microbiology. 298(1-2). 127–134. 13 indexed citations
15.
Martin, Ulrike, et al.. (2005). Interferon-γ-Induced Activation of Nitric Oxide-Mediated Antiviral Activity of Macrophages Caused by a Recombinant Coxsackievirus B3. Viral Immunology. 18(2). 355–364. 27 indexed citations
16.
Münder, Thomas, et al.. (2004). Characterization of coxsackievirus B3-caused apoptosis under in vitro conditions. Medical Microbiology and Immunology. 193(2-3). 133–139. 24 indexed citations
17.
Henke, Andreas, Roland Zell, Ulrike Martin, & A. Stelzner. (2003). Direct interferon-γ-mediated protection caused by a recombinant coxsackievirus B3. Virology. 315(2). 335–344. 24 indexed citations
18.
Bender, Armin, Hans Sprenger, Jiang-Hong Gong, et al.. (1993). The potentiating effect of LPS on tumor necrosis factor-α production by influenza a virus-infected macrophages. Immunobiology. 187(3-5). 357–371. 15 indexed citations
19.
Henke, Andreas, et al.. (1992). Lipopolysaccharide suppresses cytokine release from coxsackie virus-infected human monocytes. Research in Immunology. 143(1). 65–70. 17 indexed citations
20.
Renz, Harald, Andreas Henke, Peter Hofmann, et al.. (1992). Sensitization of rat alveolar macrophages to enhanced TNF-α release by in vivo treatment with dexamethasone. Cellular Immunology. 144(2). 249–257. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026